Physician profile
May Kim
NPI 1386844744
$1,407.34
in general payments reported to CMS, 2019-2025
19 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.12 · 2020: $55.11 · 2021: $89.08 · 2022: $171 · 2023: $432 · 2024: $422 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,079.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $233.79 | 2020-2025 | |
| Amgen INC. | $202.86 | 2019-2025 | Evenity, Prolia, Repatha |
| Merz North America, INC. | $140.63 | 2023-2024 | |
| Pfizer INC. | $128.20 | 2021-2023 | |
| Exact Sciences Corporation | $125.78 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $99.42 | 2021-2025 | Jardiance |
| Glaxosmithkline, LLC. | $74.06 | 2023-2024 | Shingrix |
| Nestle Healthcare Nutrition INC. | $65.98 | 2021-2023 | |
| Novo Nordisk INC | $64.59 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Dexcom, INC. | $41.77 | 2024 | Dexcom G6 Transmitter |
| Redhill Biopharma INC. | $33.58 | 2020 | |
| Galderma Laboratories, L.P. | $30.65 | 2022-2023 | |
| Hologic Sales and Service, LLC | $30.51 | 2025 | Aptima |
| Acella Pharmaceuticals, LLC | $29.73 | 2024 | NP Thyroid 60 |
| Arbor Pharmaceuticals, INC. | $25.51 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $22.39 | 2025 | Vyepti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.71 | 2022 | |
| Aimmune Therapeutics, INC. | $19.29 | 2024 | |
| Bioventus LLC | $17.89 | 2024 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw May Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.